The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Comparison of Intra-Articular Injections of Plasma Rich in Growth Factors (PRGF-Endoret) Versus Durolane Hyaluronic Acid in the Treatment of Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial
Abstract
PURPOSE: The purpose of this study was to compare the efficacy and safety in a randomized, clinical trial of 3 injections of PRGF-Endoret (BTI Biotechnology Institute, Vitoria, Spain) versus one single intra-articular injection of Durolane hyaluronic acid (HA) (Q-MED AB, Uppsala, Sweden) as a treatment for reducing symptoms in patients with knee osteoarthritis (OA). METHODS: Ninety-six patients with symptomatic knee OA were randomly assigned to receive PRGF-Endoret (3 injections on a weekly basis) or one infiltration with Durolane HA. The primary outcome measures were a 30% decrease and a 50% decrease in the summed score for the pain, physical function, and stiffness subscales of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Lequesne scores from baseline to weeks 24 and 48. The percentage of OMERACT-OARSI (Outcome Measures for Rheumatology Committee and Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative) responders was also documented. As secondary outcomes, pain, stiffness, and physical function by use of the WOMAC and the Lequesne score were considered and overall safety of the injection themselves. RESULTS: The mean age of the patients was 63.6 years. Treatment with PRGF-Endoret was significantly more efficient than treatment with Durolane HA in reducing knee pain and stiffness and improving physical function in patients with knee OA. The rate of response to PRGF-Endoret was significantly higher than the rate of response to HA for all the scores including pain, stiffness, and physical function on the WOMAC, Lequesne index, and OMERACT-OARSI responders at 24 and 48 weeks. Adverse events were mild and evenly distributed between the groups. CONCLUSIONS: Our findings show that PRGF-Endoret is safe and significantly superior to Durolane HA in primary and secondary efficacy analysis both at 24 and 48 weeks; provides a significant clinical improvement, reducing patients' pain and improving joint stiffness and physical function with respect to basal levels in patients with knee OA; and should be considered in the treatment of patients with knee OA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Osteoarthritis: an update with relevance for clinical practice
Bijlsma, J. W., Berenbaum, F., & Lafeber, F. P. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60243-2 · Cited by 2,288
Salaffi, F., Stancati, A., Silvestri, C. A., Ciapetti, A., & Grassi, W. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2003.09.004 · Cited by 1,724
Guccione, A. A., Felson, D. T., Anderson, J. J., Anthony, J. M., Zhang, Y., Wilson, P. W., Kelly-Hayes, M., Wolf, P. A., Kreger, B. E., & Kannel, W. B. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.3.351 · Cited by 1,584
Pham, T., van der Heijde, D., Altman, R. D., Anderson, J. J., Bellamy, N., Hochberg, M., Simon, L., Strand, V, Woodworth, T., & Dougados, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.02.001 · Cited by 849
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.06.014 · Cited by 796
Lequesne, M. G., Mery, C., Samson, M., & Gerard, P. (1987) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748709102182 · Cited by 786
Kon, E., Mandelbaum, B., Buda, R., Filardo, G., Delcogliano, M., Timoncini, A., Fornasari, P. M., Giannini, S., & Marcacci, M. (2011) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2011.05.011 · Cited by 582
Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N., & Dougados, M. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.01.005 · Cited by 578
The role of the cartilage matrix in osteoarthritis
Heinegård, D., & Saxne, T. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.198 · Cited by 553
Cited by
Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2015.08.005 · Cited by 445
Dai, W.-L., Zhou, A.-G., Zhang, H., & Zhang, J. (2017) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2016.09.024 · Cited by 444
Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021) · The American Journal of Sports Medicine · doi:10.1177/0363546520909397 · Cited by 432
Cole, B. J., Karas, V., Hussey, K., Merkow, D. B., Pilz, K., & Fortier, L. A. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546516665809 · Cited by 405
Current Clinical Recommendations for Use of Platelet-Rich Plasma
Le, A. D. K., Enweze, L., DeBaun, M. R., & Dragoo, J. L. (2018) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-018-9527-7 · Cited by 383
Metadata
- Authors
- Vaquerizo, V., Plasencia, M. Á., Arribas, I., Seijas, R., Padilla, S., Orive, G., & Anitua, E.
- Venue
- Arthroscopy: The Journal of Arthroscopic & Related Surgery
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 29
- Issue
- 10
- Pages
- 1635-1643
- ISSN
- 0749-8063 (ISSN-L)
- OpenAlex
- W2139382287
- Cited by
- 259
- References
- 27
- FWCI
- 23.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Intra-Articular Injections of Plasma Rich in Growth Factors (PRGF-Endoret) Versus Durolane Hyaluronic Acid in the Treatment of Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1016/j.arthro.2013.07.264
- The paper
- Vaquerizo, V., Plasencia, M. Á., Arribas, I., Seijas, R., Padilla, S., Orive, G., & Anitua, E. (2013). Comparison of Intra-Articular Injections of Plasma Rich in Growth Factors (PRGF-Endoret) Versus Durolane Hyaluronic Acid in the Treatment of Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery. https://doi.org/10.1016/j.arthro.2013.07.264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.